GlassScriptPhysician profile
Brandon M Lingenfelter
NPI 1790045821
$6,156.98
in general payments reported to CMS, 2019-2025
31 companies · $1,699 in 2025
The $1,699 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $250 · 2021: $693 · 2022: $378 · 2023: $2,333 · 2024: $490 · 2025: $1,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,412 · Food and Beverage: $1,570 · Consulting Fee: $350 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,412.38 |
| Food and Beverage | $1,569.90 |
| Consulting Fee | $350.00 |
| Education | $189.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,597.02 | 2021-2025 | Altaviva |
| Applied Medical Resources Corporation | $1,530.17 | 2022-2023 | |
| Astellas Pharma US INC | $683.36 | 2019-2025 | Veozah |
| Abbvie INC. | $450.26 | 2019-2025 | |
| Coloplast Corp | $431.70 | 2021-2024 | Altis, Restorelle |
| Organon LLC | $171.04 | 2021-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $127.83 | 2019-2025 | Novasure, Acessa Provu System, Aptima |
| Allergan, INC. | $123.73 | 2019-2022 | |
| Amgen INC. | $115.94 | 2019-2023 | Evenity, Prolia |
| Pfizer INC. | $115.11 | 2020-2024 | |
| Exeltis, USA INC. | $109.18 | 2021-2024 | Nuvessa, Nuvessa |
| Intuitive Surgical, INC. | $103.32 | 2021-2024 | |
| Therapeuticsmd, INC. | $100.28 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $88.87 | 2019-2021 | |
| Axonics, INC. | $77.64 | 2021-2023 | Axonics |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $37.95 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $33.45 | 2021-2022 | |
| Becton, Dickinson and Company | $32.97 | 2021 | |
| Organogenesis INC. | $29.40 | 2023-2024 | Puraply Am, Puraply |
| Medtronic USA, INC. | $23.17 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.44 | 2022 | |
| Sumitomo Pharma America, INC. | $22.23 | 2024 | Myfembree |
| Novo Nordisk INC | $18.24 | 2024 | Wegovy |
| Avanos Medical | $16.47 | 2023 | On-Q* Pump and Accessories |
| Glaxosmithkline, LLC. | $16.25 | 2021 | |
| Gynesonics, INC. | $14.61 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Supernus Pharmaceuticals, INC. | $14.12 | 2025 | Qelbree |
| Urovant Sciences INC | $13.62 | 2021 | |
| Duchesnay USA Incorporated | $13.31 | 2019 | |
| Lupin INC. | $11.97 | 2019 | |
| Minerva Surgical, INC | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Lingenfelter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.